Research Article
Maternal Opioid Drug Use during Pregnancy and Its Impact on Perinatal Morbidity, Mortality, and the Costs of Medical Care in the United States
Table 2
Ratesa of selected clinical outcomes by opioid use status and odds ratios and 95% confidence intervals for the association between opioid use and each outcome among pregnancy-related discharges, NIS, 1998–2009.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CI = confidence interval, NIS = Nationwide Inpatient Sample, OR = odds ratio, PROM = premature rupture of membranes. aPer 1,000 pregnancy-related discharges. bCrude model with maternal opioid use as the only independent variable. cModel 1 + adjustment for maternal age, household income, multiple birth, primary payer, and rural/urban status. dModel 2 + adjustment for tobacco, alcohol, maternal obesity, chronic renal failure, diabetes mellitus, and existing hypertension. eModel also adjusts for disposition at discharge. fModel also adjusts for history of depression. |